DeutschNewstral
Article
bizjournals.com on 2015-08-11 14:00
No pain, potential big gain for S.F. drug developer
Related news
- Biogen buys UK-based neuropathic pain drug developer for up to $675Mbizjournals.com
- City, developer scratching heads as $1 million in S.F. bond money disappearsbizjournals.com
- S.F. city attorney sues sinking Millennium Tower developerbizjournals.com
- Oakland, S.F. gear up for potential Warriors celebrationbizjournals.com
- BSoulCycle IPO endorphins inhibit pain potentialblogs.reuters.com
S.F. man convicted of running Silk Road underground drug websiteSan Jose Mercury News- S.F. biotech races potential COVID-19 drug toward clinical trialbizjournals.com
Get rid of all high pain/low gain court feesocregister.com
All pain no gain for many inner-city Perth homeownerswatoday.com.au- Next up for S.F. luxury condo developer? Tiny apartments in Mission, SoMabizjournals.com
- Hong Kong-based developer pays big money for S.F. land near Twitterbizjournals.com
- Hong Kong-based developer pays up for S.F. land near Twitter HQbizjournals.com
- Texas developer opens S.F. luxury apartment complex one block from Twitter HQbizjournals.com
- Exclusive: Chinese developer buys S.F. office building for $42 million, netting seller 44% profitbizjournals.com
- Developer breaks ground on two S.F. condo buildings in $1 billion pipelinebizjournals.com
- Successful Mission developer: You need lots of luck to build in this S.F. neighborhoodbizjournals.com
- Developer adds 120 apartments to wave of housing hitting S.F.'s Van Ness corridorbizjournals.com
- Pain drug developer PixarBio says it faces possible SEC lawsuitbizjournals.com
- MFDA worries about potential drug shortagesmoney.cnn.com